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2214-0247/Copyright ª 2014, TaiwanAbstract Mesenchymal stem cells (MSCs) from Wharton’s jelly have a higher proliferation
rate and self-renewal capacity than adult tissue-derived MSCs. A low oxygen level or hypoxic
condition is prevalent in the microenvironment of the stem cells in the early stages of devel-
opment. Hypoxia can influence proliferation and differentiation of various stem/precursor cell
populations. This research was conducted: to determine the proliferation rate and character-
istics of human MSCs from Wharton’s jelly in hypoxic and normoxic condition; to evaluate their
character after MSCs are incubated in hypoxic and normoxic environment using surface
markers including CD105, CD73, CD14, CD19, CD34, CD45, and HLA-II; and to evaluate the pro-
liferation rate and number of MSCs at many passages using the trypan blue method. The hyp-
oxic and normoxic microenvironment showed significant differences in the proliferation rate
and population doubling time, but and there were no differences in surface markers.
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Stem cells are currently used in clinical applications1 and
can be obtained from embryonic and extraembryonic tis-
sues and adult organs. Stem cells have the ability to prolong
self-renewal and differentiate into mature cells of various
lineages, which makes them important cell sources for
tissue engineering applications.1,2 Clinical therapies
require a large number of cells, so many strategies are used
to improve the quality and quantity of stem cells.3
The clinical therapeutic strategy uses mesenchymal stem
cells (MSCs) as cellular vehicles for the targeted delivery and
local production of biologic agents in many diseases.4 MSCs
were originally isolated from the bone marrow (BM). BM-
derived MSCs (BM-MSCs) are nonhematopoietic precursor
cells, and are capable of contributing to the maintenance and
regeneration of connective tissues through engraftment.5
However, BM-MSCs have: limited cell numbers, a risk of loss
of stem properties, chromosomal changes, and problems of
contamination, painful isolation procedure, low MSC charac-
teristics, multipotent differentiation potential, and prolifera-
tion efficiency of BM-MSCs declinewith increasing age.6e8 MSCs
are hypoimmunogenic and have the ability to promote regen-
eration and functional recovery in disease and injury, which
involves immunomodulation effects. MSCs are good candidates
for cell transplantations and allogeneic applications.9
MSCs are able to differentiate to a variety of specialized
mesenchymal tissues including bone, cartilage, muscle,
marrow stroma, tendon, ligament, fat, and connective tis-
sue.10 MSCs have been isolated from different compartments
of the umbilical cord (cord blood, umbilical cord matrix, and
the perivascular region), adult peripheral blood,11,12 adipose
tissue,13 lung,14 heart,15 trabecular bone, and dental pulp,16
and also from a variety of fetal tissues, such as the spleen,
lung, pancreas, kidneys, and amniotic fluid during midg-
estation.17MSCs canbe isolated fromWharton’s jelly (WJ), the
embryonic mucous connective tissue lying between the am-
niotic epithelium and the umbilical vessels. Wharton’s jelly-
derived MSC or WJ-MSCs have a higher proliferation rate and
self-renewal capacity than adult tissue-derived MSCs.18,19
Oxygen concentration is an important component of the
stem cell niche, where it plays an important role in main-
taining the proliferation and plasticity of stem cells.1,20 The
oxygen concentration has been investigated extensively.21
Several stem cell populations cultivated under hypoxic
condition resulted in enhanced proliferation.1 Physiological
oxygen tension of 5% instead of 2% was found to improve a
mouse embryonic stem cell line by reducing oxidative
stress.22 Hypoxic conditions have been shown to maintain
the pluripotency and minimize spontaneous differentiation
of human embryonic stem cells.20 Mammalian cells exposed
to hypoxic conditions express a variety of target genes
controlled by hypoxia inducible factor 1 to overcome hyp-
oxic stress.23 Hypoxic conditions can increase the number
of hematopoietic stem cells.24
The objective of this research was to evaluate the effect
hypoxic environment can have on the proliferation and
surface marker character of WJ-MSCs. The results of this
research may be useful from a clinical point of view, as
WJ-MSCs are used for cell therapy to repair tissue injuries,
the MSCs can encounter severe low oxygen tension.Materials and methods
Isolation and cultivation of WJ-MSCs
Fresh human umbilical cords (UC; n Z 5) were collected
from women aged 25e40 years after normal vaginal de-
livery, with informed consent using the guidelines approved
by the Institutional Ethics Committee at the Stem Cell and
Cancer Institute, Jakarta, Indonesia and from the Institu-
tional Ethics Committee collaboration between Maranatha
Christian University, Bandung, Indonesia and Immanuel
Hospital Bandung, Bandung, Indonesia.
MSCs from WJ of UC, were isolated as previously
described.3,25 UC was washed by phosphate buffer saline
(0.9% w/v sodium chloride) and cut into very small pieces,
approximately 1e2 mm, then UC was cut longitudinally, and
plated on tissue culture plastic plates. The explants were
cultured in MEMawith 2 mMGlutaMAX (Invitrogen, Carlsbad,
CA, USA), supplemented with 20% fetal bovine serum (FBS;
Invitrogen) and penicillinestreptomycineamphotericin B
(100 U/mL, 100 mg/mL, and 0.25 mg/mL; Invitrogen). Cul-
tures were incubated in a humidified atmosphere with 5%
CO2 at 37 C for 3 weeks after explantation, when fibroblast-
like adherent cells were expected to migrate from the tissue
fragments, the adherent cells and tissue fragments were
detached using trypLEeEDTA solution (TrypLE Express; Invi-
trogen) followed by washing with basal medium to remove
the trypLEeEDTA. The cells were harvested and replated at a
density 8  103 cells/cm2 when cells reached 80e90%
confluence. WJ-MSCs were cultured in 95% air (21% O2)/5%
CO2 for normoxic and hypoxic (5% and 2.5% oxygen). Hypoxia
was achieved using a tri-gas incubator (CO2 incubators with
additional process controls; BINDER GmbH, Tuttlingen,
Germany) with internal O2 and N2 tank changer for con-
necting to separate gas tanks.
Cell proliferation analysis
The effect of hypoxic and normoxic incubation towards
the cells proliferation was determined as follows. Cells
were counted and passaged at a confluence of 80%.
Briefly, cultured cells were dissociated using trypsin,
incubated for 3 minutes at 37 C, harvested and washed
using MEMa þ 20% FBS followed by centrifugation at
300  g, for 4 minutes. The cell pellet was resuspended
with trypan blue solution (0.4% in PBS, 1:1 dilution with
culture medium) for 3 minutes. The number of dead
cells (retaining the dye) was counted with a hemocy-
tometer and expressed as a percentage of the total
viable cell number. The experiments were performed in
triplicate.
At each passage, the population doubling (PD) was
determined using the formula:
PDZ ½log10ðNHÞ  log10ðNIÞ=log10 ð1Þ
where NI is the inoculum cell number and NH the cell har-
vest number. PD for each passage was calculated and added
to the PD of the previous passages in order to generate
cumulative PD data. The PD time was obtained by the
formula:
Table 1 Cumulative cell number, population doubling (PD), PD time, and cumulative PD of mesenchymal stem cells in nor-
moxic tension.
Passage Cumulative cell number PD PD time, h Cumulative PD
P1 1.82  106  1.51  105 a 1.92  0.12b 1.57  0.09a 1.57  0.09a
P2 6.90  106  4.50  105 a 1.94  0.08b 1.55  0.06a 3.12  0.08b
P3 3.52  107  1.36  106 a 2.34  0.04c 1.71  0.03a 4.83  0.05c
P4 1.71  108  2.85  107 a 2.27  0.19c 1.77  0.15a 6.60  0.19d
P5 5.65  108  5.78  107 a,b 1.73  0.13b 1.74  0.14a 8.34  0.12e
P6 1.95  109  2.97  108 b 1.78  0.08b 2.25  0.10b 10.59  0.22f
P7 4.39  109  4.57  108 c 1.18  0.10a 3.41  0.28c 14.00  0.21g
P8 1.53  1010  1.37  109d 1.80  0.08b 3.34  0.14c 17.34  0.32h
Data are presented as mean  standard deviation. Different letters in the same column (among passage) are significant at p < 0.05
(Tukey’s honestly significant differences post hoc test).
Wharton’s jelly-derived MSCs 45PD timeZ t=PD ðin hoursÞ; where tZ time ð2Þ
At the same time, a growth curve of WJ-MSCs from two
different conditions was started. Cells were seeded at 200/
cm2 in 6-well plates. Every passage (3 days culture) for
eight passages, cells from one well were harvested and
counted.
Detection of MSCs markers using fluorescence
activated cell sorting (FACS)
The WJ-MSCs were evaluated using surface marker detec-
tion at Passage 4 (P4) and P8 to confirm the effect of oxy-
gen concentration (hypoxia and normoxia) on MSC
characterization, WJ-MSCs at 80% confluence were har-
vested and dissociated with trypsin-EDTA and centrifuged
at 300  g for 10 minutes. The pellet was resuspended with
PBS þ 2% FBS, and cells were counted with a hemocytom-
eter. Between 100 cells and 200 cells in 25 mL PBS were
introduced into FACS (BD FACSCalibur ) tubes. Antibody
was then added to each FACS tube: isotype mIgG2a-PE,
CD105-PE, HLA class II-PE; isotype mIgG1-PE, CD73-PE,
CD19-PE; isotype mIgG1-FITC, CD 34-FITC, CD45-FITC,
CD14-FITC, followed by incubation at 4 C for 15 minutes.
The cells were analyzed by flow cytometry with a FACS-
Calibur 3 argon laser 488 nm (Becton Dickinson, Franklin
Lakes, NJ, USA) using CellQuest Pro Acquisition on the BD
FACStation Software. The experiments and measurement
of surface marker were performed in triplicate.Table 2 Cumulative cell number, population doubling (PD), PD t
tension (5% O2).
Passage Cumulative cell number PD ra
P1 1.80  106  1.20  105 a 1.90 
P2 6.58  106  1.30  106 a 1.86 
P3 3.33  107  7.80  106 a 2.33 
P4 1.66  108  1.76  107 a 2.34 
P5 5.20  108  8.69  107 a 1.64 
P6 1.80  109  4.64  107 a 1.77 
P7 4.60  109  1.3  109 a 1.35 
P8 1.84  1010  5.12  109b 2.01 
Data are presented as mean  standard deviation. Different letters
(Tukey’s honestly significant differences post hoc test).Results
Effect of oxygen tension on stemcell proliferation
The results of evaluating the effect of oxygen tension
(hypoxia, normoxia) on WJ-MSCs proliferation, cumulative
cell number, PD, PD time, and cumulative PD for each
passage up to P8 are in Tables 1e3. Based on these data, PD
time including normoxic, hypoxic (O2 2.5%; O2 5%) P1eP5
had the same PD time and old passage (P6eP8) had higher a
PD time than young passage on normoxic and hypoxic ten-
sion. In order to compare the cumulative cell number, PD
and PDT among incubation (normoxic and hypoxic tension)
at every passage, the data were analyzed using Tukey’s
honestly significant differences post hoc test (Tables 4
and 5). Hypoxia 2.5% had a higher cumulative cell number
compared to normoxia and hypoxia 5% at P4, P5, P6, and
P8. The cells were seeded at 480.000 cells for all treatment
(normoxia, hypoxia 5%, hypoxia 2.5%) and at all passages
(P1eP8). Table 5 shows that PD of hypoxia 2.5% at P3, P4,
P7, and P8 was higher than normoxia and hypoxia 5% O2 PD
rate. PD time hypoxia 2.5% was lower than normoxia and
hypoxia 5% at P7 and P8.Effect of oxygen tension on phenotype
Human MSCs surface marker are suggested to be positive
for CD73 and CD105 and negative for CD14, CD19, CD34, andime, and cumulative PD of mesenchymal stem cells in hypoxic
te PD time, h Cumulative PD
0.13b,c 1.59  0.10a 1.59  0.10a
0.19b,c 1.62  0.18a 3.21  0.26b
0.08c 1.72  0.06a 4.93  0.31c
0.37c 1.74  0.26a 6.67  0.14d
0.11a,b 1.83  0.13a 8.50  0.23e
0.16a,b 2.27  0.19b 10.77  0.41f
0.05a 2.98  0.12c 13.75  0.47g
0.00b,c 2.99  0.01c 16.73  0.47h
in the same column (among passage) are significant at p < 0.05
Table 3 Cumulative cell number, population doubling PD, PD time, and cumulative PD of mesenchymal stem cells in hypoxic
tension (2.5% O2).
Passage Cumulative cell number PD PD time, h Cumulative PD
P1 1.88  106  1.20  105 a 1.97  0.09a 1.53  0.07a 1.53  0.07a
P2 7.20  106  3.40  105 a 1.94  0.04a 1.55  0.04a 3.07  0.05b
P3 4.36  107  3.14  106 a,b 2.59  0.04a 1.54  0.03a 4.62  0.07c
P4 2.64  108  2.50  107 a,b 2.60  0.04a 1.54  0.03a 6.15  0.10d
P5 9.74  108  1.04  107 a,b 1.88  0.07a 1.60  0.06a 7.75  0.11e
P6 3.78  109  7.05  108 a,b 1.94  0.16b 2.07  0.17b 9.82  0.25f
P7 1.31  1010  1.93  109b 1.80  0.17c 2.23  0.22b 12.05  0.19g
P8 6.48  1010  1.2  1010 c 2.30  0.09c 2.62  0.10c 14.67  0.28h
Data are presented as mean  standard deviation. Different letters in the same column (among passage) are significant at p < 0.05
(Tukey’s honestly significant differences post hoc test).
Table 4 Cumulative cell number among normoxic and hypoxic tension.
Passage Cumulative cell number
Normoxia Hypoxia 5% Hypoxia 2.5%
P1 1.82  106  1.51  105 a 1.80  106  1.20  105 a 1.88  106  1.20  105 a
P2 6.90  106  4.50  105 a 6.58  106  1.30  106 a 7.20  106  3.40  105 a
P3 3.52  107  1.36  106 a 3.33  107  7.80  106 a 4.36  107  3.14  106 a,b
P4 1.71  108  2.85  107 a 1.66  108  1.76  107 a 2.64  108  2.50  107 b
P5 5.65  108  5.78  107 a 5.20  108  8.69  107 a 9.74  108  1.04  107 b
P6 1.95  109  2.97  108 a 1.80  109  4.64  107 a 3.78  109  7.05  108 b
P7 4.39  109  4.57  108 a 4.60  109  1.3  109 a 1.31  1010  1.93  109 b
P8 1.53  1010  1.37  109a 1.84  1010  5.12  109a 6.48  1010  1.2  1010 b
Data are presented as mean  standard deviation. Different letters in the same row (among normoxic and hypoxic) are significant at
p < 0.05 (Tukey’s honestly significant differences post hoc test).
46 W. Widowati et al.CD45.26 The effect of oxygen tension on the surface marker
of WJ-MSCs can be seen in Table 6. Table 6 shows that the
surface marker of WJ-MSCs on hypoxia and normoxia, both
P4 and P8, were not significantly different (p > 0.05).
Discussion
It has been reported that reduced oxygen tension enhances
proliferation of some cell types, for example, hypoxia (1e5
% oxygen) enhanced the self-renewal of hematopoietic
stem cells and murine embryonic stem cells in severalTable 5 Population doubling PD, PD time among normoxic and
Passage PD
Normoxia Hypoxia 5% Hypoxia 2.5
P1 1.92  0.12a 1.90  0.13a 1.97  0.09
P2 1.94  0.08a 1.86  0.19a 1.94  0.04
P3 2.34  0.04a 2.33  0.08a 2.59  0.04
P4 2.27  0.19a 2.34  0.37a 2.60  0.04
P5 1.73  0.13a 1.64  0.11a 1.88  0.07
P6 1.78  0.08a 1.77  0.16a 1.94  0.16
P7 1.18  0.10a 1.35  0.05a 1.80  0.17
P8 1.80  0.08a 2.01  0.00a 2.30  0.09
Data are presented as mean  standard deviation of PD and PD time.
PD, PDT) are significant at p < 0.05 (Tukey’s honestly significant diffprevious studies. Moreover, when rat BM-MSCs were
cultured in reduced oxygen condition, and the proliferation
of MSC was increased and had a greater number of
colonies.27e31
In the current study, the increased hypoxic (O2 2.5%)
condition was the best microenvironment for stem cells
proliferation compared to normoxic and hypoxic (O2 5%) for
cells at a high passage (P7, P8). This result was consistent
with previous reports that MSCs maintain viability when
cultured in 2%e5% O2, and increase their proliferation rate
after an initial lag phase.32 Hypoxic preconditioning of MSCshypoxic tension.
PD time, h
% Normoxia Hypoxia 5% Hypoxia 2.5%
a 1.57  0.09a 1.59  0.10a 1.53  0.07a
a 1.55  0.06a 1.62  0.18a 1.55  0.04a
b 1.71  0.03b 1.72  0.06b 1.54  0.03a
b 1.77  0.15a 1.74  0.26a 1.54  0.03a
a 1.74  0.14a 1.83  0.13a 1.60  0.06a
a 2.25  0.10a 2.27  0.19a 2.07  0.17a
b 3.41  0.29b 2.98  0.12b 2.23  0.22a
b 3.34  0.14c 2.99  0.01b 2.62  0.10a
Different letters in the same row (among normoxia and hypoxia of
erences post hoc test).
Table 6 Surface markers of mesenchymal stem cells under normoxic and hypoxic tension.
Passage CD34 CD45 CD14 CD105 CD73 CD19 HLA-II
P4
Normoxia 0.00  0.01 0.00  0.01 0.00  0.01 94.28  0.86 98.13  0.53 0.85  0.61 3.59  0.50
Hypoxia 5% 0.00  0.00 0.00  0.01 0.01  0.02 93.49  2.64 98.35  0.86 0.54  0.19 2.22  2.10
Hypoxia 2.5% 0.00  0.01 0.00  0.01 0.00  0.00 96.39  2.86 97.02  1.00 0.28  0.27 2.80  1.16
P8
Normoxia 0.00  0.00 0.00  0.01 0.01  0.01 94.87  2.57 97.99  0.92 0.94  0.64 3.80  1.96
Hypoxia 5% 0.01  0.00 0.00  0.01 0.01  0.02 96.21  2.64 99.16  0.86 0.21  0.19 2.68  2.10
Hypoxia 2.5% 0.00  0.01 0.00  0.01 0.00  0.01 95.85  0.84 97.35  1.01 0.13  0.08 1.68  1.26
Data are presented as mean  standard deviation of surface markers of mesenchymal stem cells. The treatments were triplicate.
P4 Z Passage 4; P8 Z Passage 8.
Wharton’s jelly-derived MSCs 47in 0.5% oxygen for 24 hours increased expression of pro-
survival and proangiogenic factors including hypoxia-
inducible factor 1, angiopoietin-1, and vascular endothe-
lial growth factor and its receptor. Cell death of hypoxic
stem cells and caspase-3 activation in these cells were
significantly lower compared with normoxic stem cells both
in vitro and in vivo.33 Hypoxic conditions enhance cell
amplification, and culturing under hypoxia could be an
alternative approach without the need for extra additives
to stimulate primary culture and further expansion,
yielding a sufficient supply of cells and avoiding multiple
passages.34 Low-oxygen tension is an important component
of the stem-cell microenvironment (the stem-cell niche)
and provides signals conducive to maintenance of stem-cell
function.35 Compared with the normoxic condition, hypoxia
enhances proliferation with an approximately six- to seven-
fold higher expansion of adipose tissue-derived stromal
cells over 6 weeks.36 Hypoxia provides a favorable culture
condition to promote proliferation of MSCs.37 The long-term
(1 month) effect of human MSC culture in hypoxic tension
(2% O2) showed improved survival and increased adipocytic
and osteogenic differentiation capacity.32 The MSC culture
under hypoxic conditions was associated with the induction
of hypoxia-inducing factor-a and an elevated expression of
energy metabolism-associated genes including glucose
transporter 1 (GLUT-1), lactate dehydrogenase (LDH), and
pyruvate dehydrogenase kinase 1 (PDK1).38 High concen-
trations of oxygen can cause oxidative stress via production
of reactive oxygen speciesdfree radicals that can damage
lipids, proteins, and DNA, altering cell metabolism.39 Mod-
erate hypoxia may lower intracellular reactive oxygen
species generation and accumulation and thereby increase
the metabolic efficiency.40
The flow cytometric analysis (Table 6) showed that ox-
ygen level and passage did not affect the MSC’s character.
The surface markers expression are positive for CD 105 and
CD 73 (more than 95%) and negative for CD 14, CD 19, CD
34, CD 45 and HLA-II (less than 2%). CD45 is a pan-leukocyte
marker; CD34 marks primitive hematopoietic progenitors
and endothelial cells; CD14 is prominently expressed on
monocytes and macrophages, the most likely hematopoi-
etic cells to be found in an MSC culture; CD19 is a marker of
B cells that may also adhere to MSCs in culture; and HLA-II-
DR molecules are not expressed on MSCs.41 Table 6 shows
that surface markers in hypoxic condition were not signifi-
cantly different when compared to normoxic. However, thisresult was not consistent with previous results that showed
CD90 expression reduced in BMSCs harvested under hypoxia
may be associated with improved chondrogenesis,42 hyp-
oxic culture for expansion of adipose tissue-derived stromal
cells, and maintenance of their undifferentiated state.36
In conclusion, hypoxic 2.5% O2 yield the highest prolif-
eration, and the lowest PD and PD time. Oxygen level does
not affect surface markers of WJ-MSCs at P4 or P8
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